Format

Send to

Choose Destination
Pharmacoepidemiol Drug Saf. 2019 May 8. doi: 10.1002/pds.4798. [Epub ahead of print]

Comment on "How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias".

Schuemie MJ1,2,3, Madigan D1,4, Ryan PB1,2,5, Reich C1,6, Suchard MA1,3,7,8, Berlin JA1,2, Hripcsak G1,5,9.

Author information

1
Observational Health Data Sciences and Informatics, New York, NY.
2
Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.
3
Department of Biostatistics, University of California, Los Angeles, CA.
4
Department of Statistics, Columbia University, New York, NY.
5
Department of Biomedical Informatics, Columbia University Medical Center, New York, NY.
6
Real World Analytics Solutions, IQVIA, Cambridge, MA.
7
Department of Biomathematics, University of California, Los Angeles, CA.
8
Department of Human Genetics, University of California, Los Angeles, CA.
9
Medical Informatics Services, New York-Presbyterian Hospital, New York, NY.
PMID:
31066478
DOI:
10.1002/pds.4798

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center